Publication: Evaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect
| dc.contributor.author | ÖZBAŞ, SUNA | |
| dc.contributor.authors | Ozbas-Turan, S.; Akbuga, J.; Enneli, B. | |
| dc.date.accessioned | 2022-03-12T17:38:20Z | |
| dc.date.accessioned | 2026-01-10T17:22:50Z | |
| dc.date.available | 2022-03-12T17:38:20Z | |
| dc.date.issued | 2009 | |
| dc.description.abstract | The objective of this study was to investigate the effect of different formulation parameters [i.e. molecular weight and concentration of chitosan, concentration of tripolyphosphate (TPP) and use of alginate] on physico chemical and antisense properties of antisense oligonucleotide (AsODN) loaded chitosan nanoparticles (NPs). Preparation methods of phosphodiester (PO) and phosphorothioate (PS) AsODNs-NPs were also compared. AsODNI was designed to target the beta-galactosidase (beta-gal) gene. HeLa cells were used for in vitro transfection studies and beta-gal was assayed spectrophotometrically. AsODN-NPs obtained were in general positively charged with size between 221.4-525.7 nm depending on formulation. Encapsulation efficiency of NPs depended on the type of backbone of the AsODN. PO-AsODN encapsulation into NPs (78-94%) was less efficient than PS encapsulation (91-98%). The pH of the chitosan solution affected AsODN entrapment. PO-NPs exhibited faster AsODN release than NPs containing PS. In general higher beta-gal inhibition was obtained after transfection of AsODN-NPs in cell culture studies. PS-NPs exhibited a higher inhibition effect and the highest (90.71%) inhibition was obtained with formulation PT-2. PS-adsorbed NPs showed an 88% reduction in beta-gal. This study can form the basis for forthcoming in vivo studies related to AsODN carrier systems that will use chitosan. | |
| dc.identifier.doi | 10.1691/ph.2009.9193 | |
| dc.identifier.issn | 0031-7144 | |
| dc.identifier.pubmed | 20095138 | |
| dc.identifier.uri | https://hdl.handle.net/11424/229472 | |
| dc.identifier.wos | WOS:000274307300005 | |
| dc.language.iso | eng | |
| dc.publisher | GOVI-VERLAG PHARMAZEUTISCHER VERLAG GMBH | |
| dc.relation.ispartof | PHARMAZIE | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | POLYALKYLCYANOACRYLATE NANOPARTICLES | |
| dc.subject | GENE DELIVERY | |
| dc.subject | FORMULATION | |
| dc.subject | SYSTEM | |
| dc.subject | INHIBITION | |
| dc.subject | CARRIERS | |
| dc.subject | DNA | |
| dc.title | Evaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 811 | |
| oaire.citation.issue | 12 | |
| oaire.citation.startPage | 807 | |
| oaire.citation.title | PHARMAZIE | |
| oaire.citation.volume | 64 |
